 Wysłany: Wto 22:13, 12 Kwi 2011 Temat postu: Pharmaceutical investment strategy |
|
| Pharmaceutical investment strategy:
medicine doctors recruited Bo Rui Li of business strategy VISION: . can choose to convey information within the region, according to the actual situation in each market, to take a meeting or a single centralized way of communicating with the enterprise ready for market Particularly in relation to enterprise customers the incentive to introduce new customers to problems, be sure to communicate clearly. In addition, daily work, considerable attention to the maintenance of customer relations, which through good customer relations, market development need to have been a variety of beneficial information. 2, sales policy incentives these individuals above the current market agents, their sales are always around to achieve the maximization of profits,tory burch, operating in the free market to meet their and the case of product sales and increase their corresponding additional revenue to expand the company's products can play the purpose of selling or feasible. cooperation of these companies have customers, we must first strengthen the continuous maintenance of customer relations, enhance mutual understanding. Then through the effective implementation of the For the pursuit of their interests can be met, you can set a ladder-style incentives, development of new customers based on their monthly purchase amount of the situation, to give these customers some incentives (cash incentives to the form of goods) to mobilize their initiative. January customers purchase limit new development within 3,000 yuan (including 3,000 yuan), 3% reward; customers on the purchase amount of new development 3000-5000 yuan (including 5000), 5% bonus ; customers on the purchase amount of new development 5000-10000 yuan (including 10,000 yuan), 7% of the award; new development customers purchase limit on more than 10,000 yuan, 10% of the award. (Note: The specific award criteria can be developed based on the actual situation.) 3, the market constraint control |
|
